塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/07/25 | 6,745 | 6,796 | 6,672 | 6,705 | -28 | -0.4% | 1,062,100 |
2024/07/24 | 6,822 | 6,857 | 6,721 | 6,733 | -159 | -2.3% | 896,500 |
2024/07/23 | 6,850 | 6,917 | 6,817 | 6,892 | +122 | +1.8% | 1,453,900 |
2024/07/22 | 6,750 | 6,772 | 6,678 | 6,770 | +14 | +0.2% | 897,100 |
2024/07/19 | 6,620 | 6,761 | 6,614 | 6,756 | +39 | +0.6% | 940,500 |
2024/07/18 | 6,637 | 6,780 | 6,625 | 6,717 | +92 | +1.4% | 1,035,800 |
2024/07/17 | 6,584 | 6,649 | 6,541 | 6,625 | +25 | +0.4% | 896,000 |
2024/07/16 | 6,642 | 6,671 | 6,583 | 6,600 | -43 | -0.6% | 955,800 |
2024/07/12 | 6,635 | 6,729 | 6,604 | 6,643 | -47 | -0.7% | 1,753,900 |
2024/07/11 | 6,548 | 6,718 | 6,540 | 6,690 | +228 | +3.5% | 1,957,800 |
2024/07/10 | 6,401 | 6,489 | 6,363 | 6,462 | +86 | +1.3% | 1,426,900 |
2024/07/09 | 6,283 | 6,379 | 6,262 | 6,376 | +79 | +1.3% | 1,558,700 |
2024/07/08 | 6,221 | 6,299 | 6,215 | 6,297 | +69 | +1.1% | 1,192,700 |
2024/07/05 | 6,220 | 6,262 | 6,201 | 6,228 | +32 | +0.5% | 821,700 |
2024/07/04 | 6,197 | 6,225 | 6,184 | 6,196 | +2 | ±0% | 702,700 |
2024/07/03 | 6,190 | 6,226 | 6,160 | 6,194 | -34 | -0.5% | 1,159,200 |
2024/07/02 | 6,245 | 6,259 | 6,188 | 6,228 | -4 | -0.1% | 1,223,300 |
2024/07/01 | 6,278 | 6,327 | 6,203 | 6,232 | -45 | -0.7% | 1,011,900 |
2024/06/28 | 6,278 | 6,290 | 6,239 | 6,277 | +21 | +0.3% | 1,560,100 |
2024/06/27 | 6,220 | 6,258 | 6,189 | 6,256 | +5 | +0.1% | 1,065,000 |
2024/06/26 | 6,270 | 6,293 | 6,225 | 6,251 | +27 | +0.4% | 1,614,500 |
2024/06/25 | 6,149 | 6,224 | 6,117 | 6,224 | +100 | +1.6% | 1,514,000 |
2024/06/24 | 6,012 | 6,128 | 5,980 | 6,124 | +116 | +1.9% | 1,472,100 |
2024/06/21 | 6,066 | 6,085 | 5,998 | 6,008 | -118 | -1.9% | 3,205,600 |
2024/06/20 | 6,078 | 6,146 | 6,065 | 6,126 | +58 | +1% | 1,065,200 |
2024/06/19 | 6,080 | 6,104 | 6,051 | 6,068 | -29 | -0.5% | 1,071,300 |
2024/06/18 | 6,154 | 6,169 | 6,072 | 6,097 | -50 | -0.8% | 1,407,800 |
2024/06/17 | 6,120 | 6,148 | 6,044 | 6,147 | +62 | +1% | 1,423,300 |
2024/06/14 | 6,000 | 6,117 | 6,000 | 6,085 | -9 | -0.1% | 2,187,100 |
2024/06/13 | 6,112 | 6,139 | 6,010 | 6,094 | -3 | ±0% | 1,722,200 |
2024/06/12 | 6,059 | 6,118 | 5,985 | 6,097 | -3 | ±0% | 2,892,300 |
2024/06/11 | 6,201 | 6,228 | 6,100 | 6,100 | -186 | -3% | 3,948,000 |
2024/06/10 | 6,315 | 6,319 | 6,245 | 6,286 | -15 | -0.2% | 3,027,200 |
2024/06/07 | 6,435 | 6,480 | 6,106 | 6,301 | -934 | -12.9% | 9,368,200 |
2024/06/06 | 7,208 | 7,314 | 7,188 | 7,235 | +27 | +0.4% | 968,900 |
2024/06/05 | 7,232 | 7,244 | 7,158 | 7,208 | ±0 | ±0% | 731,200 |
2024/06/04 | 7,040 | 7,208 | 7,040 | 7,208 | +90 | +1.3% | 780,700 |
2024/06/03 | 7,081 | 7,158 | 7,075 | 7,118 | +78 | +1.1% | 859,700 |
2024/05/31 | 7,046 | 7,134 | 7,022 | 7,040 | +64 | +0.9% | 4,631,200 |
2024/05/30 | 6,952 | 6,976 | 6,890 | 6,976 | -14 | -0.2% | 1,636,400 |
2024/05/29 | 6,967 | 7,003 | 6,934 | 6,990 | -7 | -0.1% | 888,500 |
2024/05/28 | 6,948 | 7,014 | 6,922 | 6,997 | +76 | +1.1% | 798,900 |
2024/05/27 | 6,901 | 6,929 | 6,867 | 6,921 | ±0 | ±0% | 731,700 |
2024/05/24 | 6,839 | 6,921 | 6,832 | 6,921 | +43 | +0.6% | 938,400 |
2024/05/23 | 6,830 | 6,899 | 6,780 | 6,878 | +104 | +1.5% | 1,408,700 |
2024/05/22 | 6,987 | 6,999 | 6,729 | 6,774 | -261 | -3.7% | 1,724,100 |
2024/05/21 | 7,086 | 7,120 | 7,030 | 7,035 | -109 | -1.5% | 1,015,800 |
2024/05/20 | 7,130 | 7,258 | 7,081 | 7,144 | +15 | +0.2% | 914,500 |
2024/05/17 | 7,138 | 7,150 | 7,084 | 7,129 | -82 | -1.1% | 725,400 |
2024/05/16 | 7,237 | 7,305 | 7,187 | 7,211 | -43 | -0.6% | 742,400 |
201~
250
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 233,900円 | +20.9% | +10.6% | 2.82% | 11.06倍 | 1.46倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 665,000円 | +2.2% | +10.2% | 1.80% | 12.77倍 | 1.28倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,300円 | +0.9% | +380.2% | 5.60% | 19.18倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 220,200円 | -3.5% | -11.3% | 2.72% | 20.23倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 387,800円 | +0.1% | -3.4% | 4.13% | 26.36倍 | 1.30倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム